All Stories

  1. Transcriptional licensing is required for Pyrin inflammasome activation in human macrophages and bypassed by mutations causing familial Mediterranean fever
  2. NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
  3. Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation
  4. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling
  5. Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice
  6. CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis
  7. Innate immune memory: a paradigm shift in understanding host defense
  8. Neutrophil extracellular trap formation in supragingival biofilms
  9. Neuroinflammation in Alzheimer's disease
  10. Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage
  11. Innate immunity in Alzheimer's disease
  12. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
  13. Synergistic activation of Toll-like receptor 8 by two RNA degradation products
  14. A transcriptional perspective on human macrophage biology
  15. The Inflammasomes and Autoinflammatory Syndromes
  16. NLRP3 Protein Deficiency Exacerbates Hyperoxia-induced Lethality through Stat3 Protein Signaling Independent of Interleukin-1β
  17. S-14
  18. 176
  19. 36
  20. 9
  21. 177
  22. 146
  23. 30
  24. Editorial overview: Special section: Effects of endogenous immune stimulants: From a defence system against infection to a homeostatic mechanism linking metabolism with inflammation
  25. Inflammasome activation in response to dead cells and their metabolites
  26. OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines
  27. LOX-1 and mitochondria: an inflammatory relationship
  28. Innate immune activation in neurodegenerative disease
  29. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
  30. Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation
  31. NLRC3 Puts the Brakes on STING
  32. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
  33. Mechanisms of Sterile Inflammation
  34. New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
  35. Dual Engagement of the NLRP3 and AIM2 Inflammasomes by Plasmodium-Derived Hemozoin and DNA during Malaria
  36. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
  37. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
  38. HIV-1 Induces the First Signal to Activate the NLRP3 Inflammasome in Monocyte-Derived Macrophages
  39. 197
  40. 63
  41. IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant?
  42. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
  43. Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis
  44. Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease
  45. Activation and regulation of the inflammasomes
  46. Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis
  47. Cholesterol Crystals and Inflammation
  48. iGLuc: a luciferase-based inflammasome and protease activity reporter
  49. The Inflammasome
  50. Mechanisms of Sterile Inflammation
  51. Assessment and Quantification of Crystal-Induced Lysosomal Damage
  52. ASC Speck Formation as a Readout for Inflammasome Activation
  53. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
  54. Noncanonical Autophagy Is Required for Type I Interferon Secretion in Response to DNA-Immune Complexes
  55. Complement dependency of cholesterol crystal-induced inflammation – I. Pathway activation mechanisms, cytokine responses and endothelial cell activation
  56. Complement dependency of cholesterol crystal-induced inflammation – II. Inflammasome activation and regulation mechanisms involving reconstituted high density lipoprotein (HDL) and C-reactive protein (CRP)
  57. HIV Type 1 Infection Up-Regulates TLR2 and TLR4 Expression and Function in Vivo and in Vitro
  58. PKR stirs up inflammasomes
  59. Inflammasomopathies: Diseases Linked to the NLRP3 Inflammasome
  60. IL-1, quo vadis?
  61. For gut's sake: NLRC4 inflammasomes distinguish friend from foe
  62. Structures of the HIN Domain:DNA Complexes Reveal Ligand Binding and Activation Mechanisms of the AIM2 Inflammasome and IFI16 Receptor
  63. NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-LIKE RECEPTOR 3 IS CRITICAL IN VASCULAR REPAIR
  64. Direct measurement of the interaction force between immunostimulatory CpG-DNA and TLR9 fusion protein
  65. Up-Regulation of TLR2 and TLR4 in Dendritic Cells in Response to HIV Type 1 and Coinfection with Opportunistic Pathogens
  66. Intracellular sensing of microbes and danger signals by the inflammasomes
  67. NLRP3 inflammasomes link inflammation and metabolic disease
  68. Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repair
  69. Getting Closer to the Dirty Little Secret
  70. Activation and Regulation of the NLRP3 Inflammasome
  71. Innate Immune Receptors for Nucleic Acids
  72. IFI16 is an innate immune sensor for intracellular DNA
  73. The Rab11a GTPase Controls Toll-like Receptor 4-Induced Activation of Interferon Regulatory Factor-3 on Phagosomes
  74. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
  75. Alternating 2′-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist
  76. Higher order structure of short immunostimulatory oligonucleotides studied by atomic force microscopy
  77. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
  78. Rational Design of Immunostimulatory siRNAs
  79. Phosphothioate oligodeoxynucleotides inhibitPlasmodiumsporozoite gliding motility
  80. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
  81. Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome
  82. Critical functions of priming and lysosomal damage for NLRP3 activation
  83. The Sterile Inflammatory Response
  84. The inflammasomes: mechanisms of activation and function
  85. Intracellular DNA recognition
  86. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts
  87. Inflammasomes: too big to miss
  88. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate
  89. Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus
  90. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
  91. 'Toll2008' outgrows its name
  92. Toll-Like Receptor Interactions Imaged by FRET Microscopy and GFP Fragment Reconstitution
  93. TLR-Independent Type I Interferon Induction in Response to an Extracellular Bacterial Pathogen via Intracellular Recognition of Its DNA
  94. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
  95. The NALP3 inflammasome is involved in the innate immune response to amyloid-β
  96. SPTLC1 Binds ABCA1 To Negatively Regulate Trafficking and Cholesterol Efflux Activity of the Transporter †
  97. Efficacy and Safety of Chaperonin 10 in Patients With Moderate to Severe Plaque Psoriasis: Evidence of Utility Beyond a Single Indication
  98. The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
  99. Corrigendum: Ligand-induced conformational changes allosterically activate Toll-like receptor 9
  100. Corrigendum: Toll-like receptor 9—dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
  101. Ligand-induced conformational changes allosterically activate Toll-like receptor 9
  102. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
  103. HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
  104. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity
  105. Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
  106. Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
  107. Mechanisms of TLR9 activation
  108. TLR9 signals after translocating from the ER to CpG DNA in the lysosome
  109. The LPS receptor generates inflammatory signals from the cell surface
  110. Receptor “cross talk” in innate immunity
  111. Receptor “cross talk” in innate immunity
  112. Lysines 128 and 132 Enable Lipopolysaccharide Binding to MD-2, Leading to Toll-like Receptor-4 Aggregation and Signal Transduction
  113. Pentoxifyllin Attenuates the Systemic Inflammatory Response Induced During Isolated Limb Perfusion With Recombinant Human Tumor Necrosis Factor-? and Melphalan
  114. IKKε and TBK1 are essential components of the IRF3 signaling pathway
  115. Cell Distributions and Functions of Toll-like Receptor 4 Studied by Fluorescent Gene Constructs
  116. Toll-like receptor 9 and systemic autoimmune diseases